David J. Jollow

15.3k total citations · 8 hit papers
94 papers, 12.7k citations indexed

About

David J. Jollow is a scholar working on Pharmacology, Molecular Biology and Physiology. According to data from OpenAlex, David J. Jollow has authored 94 papers receiving a total of 12.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pharmacology, 21 papers in Molecular Biology and 17 papers in Physiology. Recurrent topics in David J. Jollow's work include Drug-Induced Hepatotoxicity and Protection (34 papers), Pharmacogenetics and Drug Metabolism (18 papers) and Neonatal Health and Biochemistry (15 papers). David J. Jollow is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (34 papers), Pharmacogenetics and Drug Metabolism (18 papers) and Neonatal Health and Biochemistry (15 papers). David J. Jollow collaborates with scholars based in United States, Australia and Finland. David J. Jollow's co-authors include John R. Mitchell, James R. Gillette, William Z. Potter, B.B. Brodie, Nicola Zampaglione, J R Gillette, Dawn C. Davis, J.R. Mitchell, William Z. Potter and Jerry R. Mitchell and has published in prestigious journals such as Nature, The Journal of Cell Biology and Hepatology.

In The Last Decade

David J. Jollow

94 papers receiving 11.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bromobenzene-Induced Liver Necrosis. Protective Role of Glutathione and Evidence for 3,4-Bromobenzene Oxide as the Hepatotoxic Metabolite

1974 2.9k citations David J. Jollow, John R. Mitchell et al. profile →
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. IV. PROTECTIVE ROLE OF GLUTATHIONE

1973 1.5k citations David J. Jollow, William Z. Potter et al. Journal of Pharmacology and Experimental Therapeutics profile →
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. I. ROLE OF DRUG METABOLISM

1973 1.3k citations John R. Mitchell, David J. Jollow et al. Journal of Pharmacology and Experimental Therapeutics profile →
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. II. ROLE OF COVALENT BINDING IN VIVO

1973 1.0k citations David J. Jollow, John R. Mitchell et al. Journal of Pharmacology and Experimental Therapeutics profile →
Acetaminophen-induced Hepatic Necrosis

1974 894 citations David J. Jollow, William Z. Potter et al. profile →
Biological Reactive Intermediates

1977 499 citations David J. Jollow et al. profile →
Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro.

1973 428 citations William Z. Potter, Dawn C. Davis et al. profile →
Acetaminophen‐induced hepatic injury: Protective role of glutathione in man and rationale for therapy

1974 416 citations David J. Jollow et al. profile →

Peers

Countries citing papers authored by David J. Jollow

Since Specialization

Citations

This map shows the geographic impact of David J. Jollow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Jollow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Jollow more than expected).

Fields of papers citing papers by David J. Jollow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Jollow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Jollow. The network helps show where David J. Jollow may publish in the future.

Co-authorship network of co-authors of David J. Jollow

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Jollow. A scholar is included among the top collaborators of David J. Jollow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Jollow. David J. Jollow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparative metabolism and tolerability of racemic primaquine and its enantiomers in human volunteers during 7-day administration 2023 ·Frontiers in Pharmacology ·Washim Khan, Yan‐Hong Wang, Narayan D. Chaurasiya, N. P. Dhammika Nanayakkara, (unknown), (unknown), (unknown), (unknown), (unknown), James D. McChesney, Waseem Gul, Mahmoud A. ElSohly, David J. Jollow, Babu L. Tekwani, Larry Walker	2
2	Acetaminophen-Induced Hepatic Necrosis: A Reminiscence 2023 ·Drug Metabolism and Disposition ·David J. Jollow	4
3	Comparative pharmacokinetics and tissue distribution of primaquine enantiomers in mice 2022 ·Malaria Journal ·Pius S. Fasinu, Narayan D. Chaurasiya, N. P. Dhammika Nanayakkara, Yan‐Hong Wang, H. M. T. Bandara Herath, Bharathi Avula, James D. McChesney, David J. Jollow, Larry Walker, Babu L. Tekwani	4
4	Acute compartment syndrome of the lower limb following childbirth: a case report 2020 ·Journal of Medical Case Reports ·(unknown), (unknown), (unknown), (unknown), David J. Jollow	1
5	Application of Cryopreserved Human Hepatocytes in Trichloroethylene RiskAssessment: Relative Disposition of Chloral Hydrate to Trichloroacetateand Trichloroethanol 2006 ·Environmental Health Perspectives ·(unknown), David C. McMillan, JoEllyn McMillan, David J. Jollow, Lawrence C. Mohr, David G. Hoel	17
6	Primaquine-Induced Hemolytic Anemia: Role of Membrane Lipid Peroxidation and Cytoskeletal Protein Alterations in the Hemotoxicity of 5-Hydroxyprimaquine 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Zachary S. Bowman, Jason D. Morrow, David J. Jollow, David C. McMillan	34
7	Primaquine-Induced Hemolytic Anemia: Susceptibility of Normal versus Glutathione-Depleted Rat Erythrocytes to 5-Hydroxyprimaquine 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Zachary S. Bowman, John E. Oatis, (unknown), David J. Jollow, David C. McMillan	61
8	Primaquine-Induced Hemolytic Anemia: Formation of Free Radicals in Rat Erythrocytes Exposed to 6-Methoxy-8-hydroxylaminoquinoline 2002 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Andrew Gelasco, David J. Jollow, David C. McMillan	20
9	Oxidative Stress, Glucose-6-Phosphate Dehydrogenase and the Red Cell 2001 ·Advances in experimental medicine and biology ·David J. Jollow, David C. McMillan	31
10	Formation of Free Radicals and Protein Mixed Disulfides in Rat Red Cells Exposed to Dapsone Hydroxylamine 1997 ·Free Radical Biology and Medicine ·(unknown), David C. McMillan, Rosalie K. Crouch, David J. Jollow	27
11	Dapsone-Induced Hemolytic Anemia 1995 ·Drug Metabolism Reviews ·David J. Jollow, (unknown), David C. McMillan	48
12	Tolerance to Nitroglycerin in Vascular Smooth Muscle Cells Is Not Affected by the Level of Intracellular Glutathione or L-Cysteine 1995 ·Anesthesia & Analgesia ·Walter H. Newman, (unknown), (unknown), David J. Jollow, Manuel R. Castresana	4
13	Lack of in vivo evidence of a cytochrome P450 metabolite participating in aminoglycoside nephrotoxicity 1993 ·Biochemical Pharmacology ·(unknown), Mary K. Reinhard, David J. Jollow, G. H. Hottendorf	3
14	The role of N-hydroxyphenetidine in phenacetin-induced hemolytic anemia 1991 ·Toxicology and Applied Pharmacology ·(unknown), David J. Jollow	26
15	Cellular glutathione as a protective agent against 4-hydroperoxycyclophosphamide cytotoxicity in K-562 cells 1990 ·Cancer Chemotherapy and Pharmacology ·(unknown), Kevin D. Ballard, John E. Oatis, David J. Jollow, Robert K. Stuart	6
16	Acetaminophen structure-toxicity studies: In vivo covalent binding of a nonhepatotoxic analog, 3-hydroxyacetanilide 1990 ·Toxicology and Applied Pharmacology ·Stanley Roberts, Veronica F. Price, David J. Jollow	42
17	Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia. 1988 ·Journal of Pharmacology and Experimental Therapeutics ·Scott Grossman, David J. Jollow	100
18	Increased resistance of diabetic rats to acetaminophen-induced hepatotoxicity. 1982 ·Journal of Pharmacology and Experimental Therapeutics ·Veronica F. Price, David J. Jollow	72
19	Biological reactive intermediates : formation, toxicity, and inactivation 1977 ·Plenum Press eBooks ·David J. Jollow	19
20	ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. II. ROLE OF COVALENT BINDING IN VIVO breakdown → 1973 ·Journal of Pharmacology and Experimental Therapeutics ·David J. Jollow, John R. Mitchell, William Z. Potter, Dawn C. Davis, J R Gillette, B.B. Brodie	1023

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact